GlassScriptPhysician profile
John A Alton
NPI 1326024233
$5,769.63
in general payments reported to CMS, 2019-2025
44 companies · $907 in 2025
The $907 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $165 · 2021: $302 · 2022: $841 · 2023: $1,319 · 2024: $1,135 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,145 · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,145.34 |
| Education | $216.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $770.57 | 2019-2025 | Ubrelvy, Orilissa, Lo Loestrin Fe |
| Minerva Surgical, INC | $695.10 | 2019-2024 | |
| Pfizer INC. | $551.60 | 2019-2025 | |
| Astellas Pharma US INC | $481.53 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $405.97 | 2023-2025 | Myfembree |
| Organon LLC | $227.27 | 2022-2025 | Nexplanon, Jada System |
| Merck Sharp & Dohme LLC | $207.34 | 2020-2025 | Gardasil 9, Gardasil |
| Hologic Sales and Service, LLC | $190.65 | 2019-2025 | Myosure Tissue Removal Device, Aptima, Novasure |
| Exeltis, USA INC. | $190.49 | 2020-2025 | Slynd |
| Exact Sciences Corporation | $180.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Mayne Pharma Commercial LLC | $179.51 | 2021-2025 | |
| Medtronic, INC. | $159.84 | 2024-2025 | V-Loc 180 |
| Sage Therapeutics, LLC | $113.18 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $107.96 | 2021-2022 | |
| Axonics, INC. | $95.72 | 2024 | Bulkamid, Axonics |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $90.56 | 2019-2022 | |
| Coopersurgical, INC. | $81.97 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Aspira Women'S Health INC | $79.13 | 2022-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $77.67 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $77.64 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.45 | 2022-2024 | Xifaxan |
| Millicent US INC | $64.50 | 2024 | Femring, Intrarosa |
| Agile Therapeutics, INC. | $61.83 | 2022-2024 | Twirla |
| Optumhealth Care Solutions, LLC | $59.50 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Daiichi Sankyo INC. | $59.32 | 2023-2024 | Injectafer |
| Allergan, INC. | $58.51 | 2019 | |
| Amgen INC. | $48.61 | 2020-2025 | Evenity |
| Therapeuticsmd, INC. | $41.05 | 2019 | |
| Duchesnay USA Incorporated | $38.39 | 2019 | |
| Smith+Nephew, INC. | $35.67 | 2025 | Pico |
| Baxter Healthcare | $31.81 | 2023 | Floseal |
| Becton, Dickinson and Company | $25.38 | 2025 | Bd Max System, Bd Max Instrument |
| Boston Scientific Corporation | $24.79 | 2025 | Axonics |
| Meditrina | $23.34 | 2024 | |
| Gynesonics, INC. | $20.64 | 2022 | |
| Dilon Technologies, INC. | $20.17 | 2025 | Hemoblast Bellows |
| Shield Therapeutics INC | $18.95 | 2024 | |
| Olympus America INC. | $17.38 | 2019 | |
| Evofem Biosciences, INC. | $17.37 | 2021 | |
| Avanos Medical | $15.97 | 2019 | |
| Lilly USA, LLC | $15.92 | 2025 | Zepbound |
| Vertex Pharmaceuticals Incorporated | $14.26 | 2024 | |
| Scynexis, INC. | $12.30 | 2022 | |
| Mission Pharmacal Company | $12.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Alton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.